Clinical-stage pharma stock Theralase Technologies (TSXV:TLT) announced a significant breakthrough in the treatment of Herpes ...

University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection. TORONTO, ON / ACCESS Newswire / ...

University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection. TORONTO, ON / ACCESS Newswire / Febru ...

Scientists have identified nanoparticles that latch onto and destroy virus membranes, opening new possibilities for antiviral ...

Rhinoviruses are known as the most common cause of the common cold. However, the virus can cause a range of symptoms. This ...

Cases of Rhinovirus are on the rise across the UK, with young children being particularly affected. Government data from its weekly virus update show that Rhinovirus positivity has gone up to 9.7% ...

Rhinovirus, known to be the most frequent cause of the common cold, is the only virus which has seen cases rise in the last week or so compared to Coronavirus, RSV and influenza ...

Cases of another horror winter flu virus are surging across the UK alongside Coronavirus and HMPV, new Government data has shown - with young children most at risk ...

Aethlon announces first patient enrolled and treated with the Hemopurifier at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital: San Diego Friday, January 31, 2025, 1 ...

A new way to neutralize coronavirus and other membrane-surrounded viruses has been discovered by researchers from the Swedish ...

US-based Aethlon Medical has treated the first subject with its Hemopurifier investigational device in its Australian cancer ...

Certain mineral nanoparticles were found to damage the membrane of the virus, making it less able to enter human cells. The mode of action that is demonstrated has not been discussed in previous ...